JBIO
Jade Biosciences Inc

610
Mkt Cap
$605.88M
Volume
16,532.00
52W High
$100.10
52W Low
$6.57
PE Ratio
-1.16
JBIO Fundamentals
Price
$13.72
Prev Close
$13.17
Open
$13.72
50D MA
$12.65
Beta
-1.17
Avg. Volume
397,465.73
EPS (Annual)
-$85.26
P/B
2.40
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Jade Biosciences (NASDAQ:JBIO) Shares Gap Down - Time to Sell?
Jade Biosciences (NASDAQ:JBIO) Shares Gap Down - Time to Sell...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Jade Biosciences (NASDAQ:JBIO) Trading Down 3.7% - Here's Why
Jade Biosciences (NASDAQ:JBIO) Shares Down 3.7% - What's Next...
MarketBeat·8d ago
News Placeholder
Jade Biosciences (NASDAQ:JBIO) Stock Price Up 4.5% - Here's What Happened
Jade Biosciences (NASDAQ:JBIO) Trading Up 4.5% - Here's What Happened...
MarketBeat·14d ago
News Placeholder
Jade Biosciences, Inc. (NASDAQ:JBIO) Receives Average Recommendation of "Moderate Buy" from Analysts
Shares of Jade Biosciences, Inc. (NASDAQ:JBIO - Get Free Report) have been assigned an average rating of "Moderate Buy" from the five research firms that are covering the stock, Marketbeat Ratings...
MarketBeat·15d ago
News Placeholder
Jade Biosciences (NASDAQ:JBIO) Trading Down 4.5% - Here's What Happened
Jade Biosciences (NASDAQ:JBIO) Stock Price Down 4.5% - Here's What Happened...
MarketBeat·16d ago
News Placeholder
Jade Biosciences (NASDAQ:JBIO) Trading 7.4% Higher - Here's What Happened
Jade Biosciences (NASDAQ:JBIO) Stock Price Up 7.4% - Time to Buy...
MarketBeat·26d ago
News Placeholder
Jade Biosciences (NASDAQ:JBIO) Sees Large Volume Increase - Here's What Happened
Jade Biosciences (NASDAQ:JBIO) Sees Large Volume Increase - Should You Buy...
MarketBeat·1mo ago
News Placeholder
Geode Capital Management LLC Purchases Shares of 676,431 Jade Biosciences, Inc. $JBIO
Geode Capital Management LLC acquired a new position in shares of Jade Biosciences, Inc. (NASDAQ:JBIO - Free Report) during the 2nd quarter, according to its most recent disclosure with the...
MarketBeat·1mo ago
News Placeholder
Does Jade Biosciences, Inc. (JBIO) Have the Potential to Rally 65% as Wall Street Analysts Expect?
The mean of analysts' price targets for Jade Biosciences, Inc. (JBIO) points to a 65% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks·1mo ago
News Placeholder
Jade Biosciences, Inc. (NASDAQ:JBIO) Receives Average Rating of "Moderate Buy" from Analysts
Shares of Jade Biosciences, Inc. (NASDAQ:JBIO - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the five ratings firms that are covering the stock, MarketBeat.com...
MarketBeat·1mo ago
<
1
2
...
>

Latest JBIO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.